Home > Insider Trading > Filing (0000899243-18-027509)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1664106	Logicbio Therapeutics Inc.	LOGC	Biological Products, (No Disgnostic Substances) (2836)	471514975

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1700449	Plc Bioscience Arix	20 Berkeley Square Mayfair, London X0 W1J 6EQ		No	No	Yes	No
1756884	Ltd Holdings Bioscience Arix	20 Berkley Square Mayfair, London X0 W1J6EQ		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-10-23	2,279,023	$0.00	2,279,023	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2018-10-23	700,000	$10.00	2,979,023	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2018-10-23	4,352,775	$0.00	2,279,023	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

The Series B Preferred Stock converted into LogicBio Therapeutics, Inc. (the "Issuer") common stock effective upon closing of the Issuer's initial public offering.
These shares are owned directly by Arix Bioscience Holdings Limited, which is a wholly owned subsidiary of Arix Bioscience Plc. Arix Bioscience Plc is an indirect beneficial owner of the reported securities and disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.